Logo image of CXW

CORECIVIC INC (CXW) Stock Fundamental Analysis

USA - NYSE:CXW - US21871N1019 - Common Stock

17.96 USD
+0.22 (+1.24%)
Last: 10/17/2025, 4:15:00 PM
17.96 USD
0 (0%)
After Hours: 10/17/2025, 4:15:00 PM
Fundamental Rating

5

Taking everything into account, CXW scores 5 out of 10 in our fundamental rating. CXW was compared to 84 industry peers in the Commercial Services & Supplies industry. CXW has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on CXW. These ratings could make CXW a good candidate for value investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CXW was profitable.
CXW had a positive operating cash flow in the past year.
CXW had positive earnings in 4 of the past 5 years.
In the past 5 years CXW always reported a positive cash flow from operatings.
CXW Yearly Net Income VS EBIT VS OCF VS FCFCXW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

CXW has a Return On Assets of 3.39%. This is in the better half of the industry: CXW outperforms 66.67% of its industry peers.
The Return On Equity of CXW (7.04%) is better than 63.10% of its industry peers.
CXW has a Return On Invested Capital (5.45%) which is comparable to the rest of the industry.
CXW had an Average Return On Invested Capital over the past 3 years of 4.72%. This is significantly below the industry average of 10.17%.
The 3 year average ROIC (4.72%) for CXW is below the current ROIC(5.45%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.39%
ROE 7.04%
ROIC 5.45%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
CXW Yearly ROA, ROE, ROICCXW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

CXW has a better Profit Margin (5.21%) than 67.86% of its industry peers.
CXW's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 10.39%, CXW is doing good in the industry, outperforming 72.62% of the companies in the same industry.
CXW's Operating Margin has declined in the last couple of years.
CXW has a Gross Margin of 24.70%. This is in the lower half of the industry: CXW underperforms 61.90% of its industry peers.
CXW's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.39%
PM (TTM) 5.21%
GM 24.7%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
CXW Yearly Profit, Operating, Gross MarginsCXW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CXW is destroying value.
The number of shares outstanding for CXW has been reduced compared to 1 year ago.
The number of shares outstanding for CXW has been reduced compared to 5 years ago.
CXW has a better debt/assets ratio than last year.
CXW Yearly Shares OutstandingCXW Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CXW Yearly Total Debt VS Total AssetsCXW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CXW has an Altman-Z score of 1.58. This is a bad value and indicates that CXW is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.58, CXW is in line with its industry, outperforming 40.48% of the companies in the same industry.
The Debt to FCF ratio of CXW is 5.98, which is a neutral value as it means it would take CXW, 5.98 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CXW (5.98) is better than 66.67% of its industry peers.
CXW has a Debt/Equity ratio of 0.68. This is a neutral value indicating CXW is somewhat dependend on debt financing.
The Debt to Equity ratio of CXW (0.68) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 5.98
Altman-Z 1.58
ROIC/WACC0.67
WACC8.11%
CXW Yearly LT Debt VS Equity VS FCFCXW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CXW has a Current Ratio of 1.60. This is a normal value and indicates that CXW is financially healthy and should not expect problems in meeting its short term obligations.
CXW has a Current ratio (1.60) which is comparable to the rest of the industry.
CXW has a Quick Ratio of 1.60. This is a normal value and indicates that CXW is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CXW (1.60) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
CXW Yearly Current Assets VS Current LiabilitesCXW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

CXW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.33%, which is quite impressive.
The earnings per share for CXW have been decreasing by -17.17% on average. This is quite bad
CXW shows a small growth in Revenue. In the last year, the Revenue has grown by 1.62%.
Measured over the past years, CXW shows a decrease in Revenue. The Revenue has been decreasing by -0.19% on average per year.
EPS 1Y (TTM)58.33%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%111.76%
Revenue 1Y (TTM)1.62%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%9.81%

3.2 Future

CXW is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 57.86% yearly.
Based on estimates for the next years, CXW will show a quite strong growth in Revenue. The Revenue will grow by 9.81% on average per year.
EPS Next Y89.58%
EPS Next 2Y57.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.9%
Revenue Next 2Y9.81%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CXW Yearly Revenue VS EstimatesCXW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
CXW Yearly EPS VS EstimatesCXW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.91, CXW is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of CXW indicates a somewhat cheap valuation: CXW is cheaper than 70.24% of the companies listed in the same industry.
CXW is valuated rather cheaply when we compare the Price/Earnings ratio to 27.29, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.82, which indicates a very decent valuation of CXW.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CXW indicates a rather cheap valuation: CXW is cheaper than 82.14% of the companies listed in the same industry.
CXW's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.85.
Industry RankSector Rank
PE 18.91
Fwd PE 11.82
CXW Price Earnings VS Forward Price EarningsCXW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CXW is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CXW is valued cheaply inside the industry as 86.90% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.26
EV/EBITDA 8.37
CXW Per share dataCXW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CXW's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CXW's earnings are expected to grow with 57.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y57.86%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CXW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CORECIVIC INC

NYSE:CXW (10/17/2025, 4:15:00 PM)

After market: 17.96 0 (0%)

17.96

+0.22 (+1.24%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-05 2025-11-05
Inst Owners90.41%
Inst Owner Change-0.02%
Ins Owners1.26%
Ins Owner Change-5.21%
Market Cap1.92B
Analysts80
Price Target30.09 (67.54%)
Short Float %2.53%
Short Ratio2.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-76.74%
DP0.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)81.38%
Min EPS beat(2)78.22%
Max EPS beat(2)84.54%
EPS beat(4)4
Avg EPS beat(4)86.21%
Min EPS beat(4)68.32%
Max EPS beat(4)113.77%
EPS beat(8)6
Avg EPS beat(8)43.4%
EPS beat(12)9
Avg EPS beat(12)30.73%
EPS beat(16)10
Avg EPS beat(16)21.5%
Revenue beat(2)2
Avg Revenue beat(2)3.98%
Min Revenue beat(2)1.11%
Max Revenue beat(2)6.86%
Revenue beat(4)4
Avg Revenue beat(4)3.39%
Min Revenue beat(4)1.11%
Max Revenue beat(4)6.86%
Revenue beat(8)7
Avg Revenue beat(8)2.28%
Revenue beat(12)7
Avg Revenue beat(12)0.98%
Revenue beat(16)7
Avg Revenue beat(16)0.19%
PT rev (1m)-4.58%
PT rev (3m)-6.35%
EPS NQ rev (1m)-2.86%
EPS NQ rev (3m)15.74%
EPS NY rev (1m)-1.29%
EPS NY rev (3m)23.34%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)4.11%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)3.63%
Valuation
Industry RankSector Rank
PE 18.91
Fwd PE 11.82
P/S 0.96
P/FCF 11.26
P/OCF 7.07
P/B 1.3
P/tB 1.31
EV/EBITDA 8.37
EPS(TTM)0.95
EY5.29%
EPS(NY)1.52
Fwd EY8.46%
FCF(TTM)1.6
FCFY8.88%
OCF(TTM)2.54
OCFY14.14%
SpS18.66
BVpS13.8
TBVpS13.76
PEG (NY)0.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.39%
ROE 7.04%
ROCE 7.5%
ROIC 5.45%
ROICexc 5.72%
ROICexgc 5.73%
OM 10.39%
PM (TTM) 5.21%
GM 24.7%
FCFM 8.55%
ROA(3y)2.77%
ROA(5y)1.65%
ROE(3y)5.91%
ROE(5y)3.57%
ROIC(3y)4.72%
ROIC(5y)4.97%
ROICexc(3y)4.95%
ROICexc(5y)5.26%
ROICexgc(3y)4.97%
ROICexgc(5y)5.28%
ROCE(3y)6.5%
ROCE(5y)6.83%
ROICexcg growth 3Y-6%
ROICexcg growth 5Y-3.21%
ROICexc growth 3Y-5.99%
ROICexc growth 5Y-2.92%
OM growth 3Y-11.18%
OM growth 5Y-7.87%
PM growth 3YN/A
PM growth 5Y-18.12%
GM growth 3Y-5.42%
GM growth 5Y-3.25%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 5.98
Debt/EBITDA 3.02
Cap/Depr 80.43%
Cap/Sales 5.06%
Interest Coverage 2.77
Cash Conversion 81.6%
Profit Quality 164.18%
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z 1.58
F-Score8
WACC8.11%
ROIC/WACC0.67
Cap/Depr(3y)58.14%
Cap/Depr(5y)58%
Cap/Sales(3y)3.91%
Cap/Sales(5y)4.1%
Profit Quality(3y)195.22%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.33%
EPS 3Y25.31%
EPS 5Y-17.17%
EPS Q2Q%111.76%
EPS Next Y89.58%
EPS Next 2Y57.86%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.62%
Revenue growth 3Y1.74%
Revenue growth 5Y-0.19%
Sales Q2Q%9.81%
Revenue Next Year8.9%
Revenue Next 2Y9.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.68%
EBIT growth 3Y-9.64%
EBIT growth 5Y-8.05%
EBIT Next Year107.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.59%
FCF growth 3Y2.78%
FCF growth 5Y4.21%
OCF growth 1Y46.88%
OCF growth 3Y0.74%
OCF growth 5Y-5.35%